August 2006, Provided long-term scientific consultancy services to a globally-successful, London-based biotechnology company

February 2006, Provided specific, compound-related regulatory consultancy services to a virtual Swiss/US pharmaceutical development company

October 2006, Recruited as Chief Scientific Officer to a UK start-up contract R&D organisation until February 2009 (White Rose Consulting Ltd on hold during this period)

October 2004, Provided annual training module on stability testing of clinical trial materials, to an EU training organisation

April 2005, Agreement reached to provide contract business development services to a specialist niche EU company with expertise in gamma scintigraphy and MRI studies in drug development.

March 2005, Conducted a 1-day fast-track introductory training course to the pharmaceutical industry, focussing on GMP manufacture and sales / marketing (6-monthly event).

January 2005, Organised and ran a 2-day international conference in London on stability testing requirements for biotechnology molecules.

October 2004, Agreement reached to provide contract business development services to a major IP-based EU pulmonary drug delivery company.

October 2004, Agreement reached to provide CMC business development services to an EU contract Research Organisation.

July 2004, Agreement reached with two London-based agencies to provide Pharmaceutical Sciences interim management services

July 2004, Established links with an EU pharmaceutical company to provide a detailed Development Guide

July 2004, Selected by an international training course organising body to design two customised courses on Key Account Management and Stability Testing specifically to pharma client companies.

June 2004, Agreement reached with UK search and selection agency to provide specific advice on role selection

June 2004, Working with another group of consultants to advise on biotechnology start-up logistics

May 2004, Company founded and incorporated at Companies House, UK

"Creep Behaviour of Microcrystalline Cellulose in Silicone Oil at Low Applied Electric Fields” (Poster). J L Davies, J N Staniforth, I S Blagborough, D Jordan, AAPS Conf., 1998, San Francisco.

"A Study of Tacrine Diffusion from Silicone Oil using a Modified Franz Cell” (Poster). J L Davies, J N Staniforth, I S Blagborough, D Jordan, AAPS Conf., 1998, San Francisco.

"The Degradation and Characterisation of Different Molecular Weight Grades of Poly (E-Caprolactone)”, J.Pharm. Pharmac., Dec 1991

"The Effect of Varying the Electrical Resistivity of Powder Compacts on their Voltage Decay Properties”. Inst Phy Conf Ser No. 118 Sect. 4 (1991)

"A Short Formulary for Semi-Solid Matrices for Hard gelatin Capsules” Proceedings of APV Conference, Hamburg, 1988

"Gastroadhesives in Controlled Drug Delivery” First Int Workshop of the APV and CRS, Leiden, 22-24 May 1989, Chapter XI, p165 – 177

“Liquid Filling of Hard Gelatin Capsules” D Jordan, P Flanders, London, June 1989, Capsugel Symposium Papers, 11 – 17

“The Control of Drug Release from Conventional Melt Granulation Matrices” P Flanders, G A Dyer, D Jordan, Drug Dev Ind Pharm, 1987, 13 (6), 1001 – 1023

“Rocking cylinder dissolution apparatus” B.P. Conf. St. Andrews, 1976

“Influence des variations thermique sur les characteristiques des bases pour suppositoires” First Int. Conf. Pharm. Tech. (Paris) 4, 51, 1976

“Studies in Dissolution and Crystal Growth of Sulphathiazole” D Jordan PhD Thesis 1975

“The Thermodynamic Properties of Sulphathiazole” D Jordan, J E Carless, J Pharm. Pharmac. 1974, 26, 86p – 87p

“The Dissolution Kinetics of Sulphathiazole Form I” J E Carless, D Jordan, J Pharm. Pharmac. 1974, 26, 85p – 86p

“The Crystallisation Behaviour of Sulphathiazole” D Jordan, J E Carless, J Pharm. Pharmac. 1976, 28, 410 – 414

Registered office: 3 Leary Crescent, Newport Pagnell, Buckinghamshire, MK16 9GA, United Kingdom